News

QualTex Laboratories, a subsidiary of BioBridge, offers a variety of ways for you to stay connected with us and our subsidiaries. You can read our latest press releases or Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information.

We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact;
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

December 4, 2015

For the second year in a row, BioBridge Global will be serving as an organizing sponsor of the World Stem Cell Summit. The 2015 summit is next week in Atlanta.

Executives from BBG will be participating in multiple sessions at the event, which is coordinated by the Genetic Policy Institute and runs Dec. 10-12. BioBridge Global was an organizing sponsor of the 2014 summit, which was in San Antonio.

BBG subsidiary QualTex Laboratories operates a major facility in the Atlanta metro area.

October 26, 2015

Changing just one letter of the DNA of red blood cells holds the promise for a cure to sickle cell anemia and similar blood disorders, Australian researchers have found.

A study at the University of New South Wales shows that a single genetic modification – which essentially switches on a gene that is sleeping in most people after birth – can increase the production of oxygen-carrying hemoglobin.

“An exciting new age of genome editing is beginning, now that single genes within our vast genome can be precisely cut and repaired,” Merlin Crossley, Dean of Science at the university and the lead researcher in the study, said in a university news release.

September 14, 2015

A simple blood test could replace expensive and often-invasive biopsies for detecting cancer, according to research presented recently by researchers from the United Kingdom.

A blood test to establish the presence of cancerous cells would offer a quicker diagnosis at a fraction of the cost of a biopsy, said Eric Lim, consultant thoracic surgeon at Royal Brompton & Harefield National Health Service Foundation Trust.

A 2014 report showed the typical biopsy cost more than $14,000.

The UK study involved blood testing of 223 patients with known or suspected primary or secondary lung cancer. The test was accurate in almost 70 percent of the cases.

The test detects three cancer-specific gene mutations in the bloodstream. The researchers said similar gene patterns in lung and colorectal cancer would make the test useful for finding both forms of cancer.

August 31, 2015

All blood donations made in this country are required to undergo testing for certain diseases, following guidelines established by the U.S. Food and Drug Administration.

The testing is intended to prevent the spread of blood-borne diseases via transfusion. QualTex Laboratories provides the testing for samples for the South Texas Blood & Tissue Center and centers across the United States.

The FDA-recommended tests are for:

Executives from BBG, South Texas Blood & Tissue Center, QualTex Laboratories and GenCure Emphasize Cooperation, Teamwork
August 21, 2015

With everything from a singing vice president to a 7-foot-3 blood drop prancing around the grounds, last week was a memorable one at BioBridge Global (BBG).

It was all part of BBG Team Week, which rolled together five days of activities that even included a major blood drive sponsored by two San Antonio television stations.

“BBG Team Week was remarkable in many ways,” said chief executive officer Linda Myers. “It was great to see people and the organization in a whole new light, and a great way for us to engage with people who do lifesaving work every day. It really was a team-building experience.”

Pages